Product NDC: | 15054-0211 |
Proprietary Name: | APOKYN |
Non Proprietary Name: | APOMORPHINE HYDROCHLORIDE |
Active Ingredient(s): | 30 mg/3mL & nbsp; APOMORPHINE HYDROCHLORIDE |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 15054-0211 |
Labeler Name: | Tercica, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021264 |
Marketing Category: | NDA |
Start Marketing Date: | 20040702 |
Package NDC: | 15054-0211-5 |
Package Description: | 5 CARTRIDGE in 1 CARTON (15054-0211-5) > 3 mL in 1 CARTRIDGE (15054-0211-1) |
NDC Code | 15054-0211-5 |
Proprietary Name | APOKYN |
Package Description | 5 CARTRIDGE in 1 CARTON (15054-0211-5) > 3 mL in 1 CARTRIDGE (15054-0211-1) |
Product NDC | 15054-0211 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | APOMORPHINE HYDROCHLORIDE |
Dosage Form Name | INJECTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20040702 |
Marketing Category Name | NDA |
Labeler Name | Tercica, Inc. |
Substance Name | APOMORPHINE HYDROCHLORIDE |
Strength Number | 30 |
Strength Unit | mg/3mL |
Pharmaceutical Classes | Dopamine Agonists [MoA],Dopaminergic Agonist [EPC] |